FDA: Makary out, Pharma-Ghoul in

About this episode

The episode discusses the implications of Kyle Diamantas's appointment to the FDA and the associated concerns regarding pharmaceutical company influence and regulatory failures.

The Nurses Report with Ashley, Nicole, & David – FDA leadership shifts as Kyle Diamantas steps into power, raising alarms over his past work defending pharmaceutical companies in Abilify litigation. The story connects Mirapex, hidden safety signals, sealed settlements, and regulatory failure, arguing that drug victims face impossible burdens while pharma profits from secrecy, influence, and institutional protection today...

People in this episode

Hosts: Ashley, Nicole, David

Topics covered

• FDA leadership
• pharmaceutical litigation
• drug safety
• regulatory failure
• pharma influence

Keywords

• FDA
• Kyle Diamantas
• pharmaceutical companies
• Abilify
• Mirapex
• drug safety
• regulatory failure

Mentioned in this episode

Organizations: FDA, pharmaceutical companies

Products: Abilify, Mirapex

More episodes of Law and Legal | America Out Loud News

• Connecticut declares war on homeschool families · June 12, 2026 · 57 min
• SPLC indicted for alleged role in Charlottesville rally · June 11, 2026 · 57 min
• Rigged – California: How laws, and ballots, shape the perception of election integrity · June 10, 2026 · 57 min
• A weapon, a ‘kill list,’ and a parent who refused to stay silent · June 10, 2026 · 57 min
• Who is Jimmy Lai and why is Hong Kong jailing him? · June 10, 2026 · 58 min
• Heroic Reiner Fuellmich is still imprisoned by Germany · June 8, 2026 · 57 min